Chlorpromazine Equivalents Versus Defined Daily Doses: How to Compare Antipsychotic Drug Doses?

Journal of Clinical Psychopharmacology

Volumn 23, Issue 6, 2003, Pages 657-659

  Rijcken, Claudia A W ^a   Monster, Taco B M ^a   Brouwers, Jacobus R B J ^a   De Jong Van Den Berg, Lolkje T W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOPHENAZINE; BUTAPERAZINE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOPENTHIXOL; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LOXAPINE; MESORIDAZINE; MOLINDONE; MOPERONE; NEUROLEPTIC AGENT; PERICIAZINE; PERPHENAZINE; PIMOZIDE; PIPAMPERONE; PROCHLORPERAZINE; PROMAZINE; SULPIRIDE; THIOPROPAZATE; THIOPROPERAZINE; THIORIDAZINE; TIAPRIDE; TIOTIXENE; TRIFLUOPERAZINE; TRIFLUPROMAZINE; UNINDEXED DRUG;

ARTICLE; COMPARATIVE STUDY; DATA ANALYSIS; DRUG BIOAVAILABILITY; DRUG DOSE REGIMEN; DRUG POTENCY; DRUG SCREENING; DRUG USE; LINEAR REGRESSION ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADULT; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; REPRODUCIBILITY OF RESULTS; THERAPEUTIC EQUIVALENCY;

EID: 0344420418     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000096247.29231.3a     Document Type: Article

References (4)

1. Rey MJ, Schulz P, Costa C, et al. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychol. 1989;4:95-104.
2. WHO. Collaborating Centre for Drug Statistics Methodology Available at: http.//www.whocc.no/atcddd/. Accessed May 2002.
3. APA. Treatment of Patients with Schizophrenia: Practice Guidelines for the Treatment of Psychiatric Disorders. Washington: APA; 2002.
4. WHO. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index With DDDs 2001: Oslo, WHO; 2001.